VTAK
Catheter Precision, Inc. (AMEX)
Healthcare — Medical Devices
Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States and Europe. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures; and LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures. Catheter Precision, Inc. was formerly known as Catheter Robotics Inc. The company is based in Fort Mill, South Carolina.
Price History
Fundamentals
| Market Cap | $2.23M |
| P/E Ratio (TTM) | - |
| Forward P/E | -0.22 |
| EPS (TTM) | $-10.48 |
| Dividend Yield | - |
| Profit Margin | - |
| Revenue Growth | 202.10% |
| ROE | -179.70% |
| Debt/Equity | 130.98 |
| Recommendation | None |
| Analyst Target | - |
| Analysts | - |
| Indexes | AMEX |
Technical Indicators
| RSI (14) | 38.2 |
| Beta | 0.34 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $4.94 |
| 52-Week Low | $0.75 |
| 50-Day Avg | $0.93 |
| 200-Day Avg | $1.70 |
| Avg Volume | $3.15M |
| Volume | 75.6K |
Performance Analysis
NEUTRALVTAK presents a mixed picture with both positive and negative indicators.
Recent News
Last updated: Jul 02, 2026 13:37 UTC
Back to Screener Export Report